Company intelligence / Profile preview

Tianjin Pacific

Tianjin, Tianjin, China
Ownership
Private
Development stage
Other
01

Overview

Tianjin Pacific Pharmaceutical Co., Ltd. is a specialized pharmaceutical manufacturer located in the Tianjin Economic-Technological Development Area, China. Operating as a subsidiary of the Tianjin Pharmaceutical Group, the company is dedicated to the development and production of chemical drug formulations. Its core therapeutic focus includes cardiovascular diseases, respiratory conditions, and gastrointestinal health. The company's manufacturing facilities are equipped with advanced production lines for tablets, capsules, and granules, all of which meet national GMP certification standards. Tianjin Pacific is recognized for its flagship products like Nifedipine and Cimetidine, which serve a broad patient base in the domestic market. Through continuous quality improvement and technical innovation, the company maintains a strong reputation for reliability and excellence in the Chinese pharmaceutical industry.

Therapeutic areas
CardiovascularPulmonologyGastroenterology
Modalities
Small molecule
Industry
Biotech

Beyond the preview

Go deeper on Tianjin Pacific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tianjin Pacific.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call